CLINICAL_TRIALS
trial_result
· 2017-11-17
Clinical Trial Update: Progesterone for Smoking Relapse Prevention Following Delivery [Phase 2]
Summary
Phase 2 clinical trial evaluating progesterone to prevent smoking relapse after delivery; study completed with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Tobacco Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-11-17